MPM Corporeos

MPM Corporeos P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of MPM Corporeos (ESPA3.SA) as of Nov 4, 2026 is 5.61. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 4.27 — a change of 31.16% (higher).

P/FCF

5.61

YoY

31.16%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of MPM Corporeos is 2025 5.61 . P/FCF (Price-to-Free-Cash-Flow Ratio) of MPM Corporeos was 2024 4.27 . It decreases by 31.16% higher compared to the previous year.

The MPM Corporeos P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
-21.82 BRL
Jan 1, 2019
-12.22 BRL
Jan 1, 2020
6.82 BRL
Jan 1, 2021
-2.86 BRL
Jan 1, 2022
-7.60 BRL
Jan 1, 2023
13.38 BRL
Jan 1, 2024
4.27 BRL
Jan 1, 2025
5.61 BRL
The MPM Corporeos P/FCF history
YEARP/FCFYoY
5.61+31.16%
4.27-68.05%
13.38-275.94%
-7.60+165.92%
-2.86-141.91%
6.82-155.84%
-12.22-44.01%
-21.82-22.34%
-28.10-105.97%
470.65—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MPM Corporeos Stock analysis

What does MPM Corporeos do? MPM Corporeos SA generates revenue through its branded aesthetic service offerings. The company operates under the Espacolaser brand in Brazil, providing laser hair removal across 35 body areas for women and 29 areas for men in both owned and franchised stores. In Argentina, it serves customers via the Definit brand with similar hair removal services. Additionally, the Estudioface brand delivers facial aesthetics treatments including botox injections, fillers, laser facial procedures, and peeling. These services target both male and female clients across all Brazilian states and Argentina, with the company's revenue streams derived from the sale of these specific treatment packages through its branded platforms. The Espacolaser brand dominates the Brazilian market, offering comprehensive hair removal solutions across the country's states. Definit serves the Argentine market with comparable services, while Estudioface focuses on facial aesthetics with procedures like botulinum toxin applications. Each brand operates within its designated geographic region, targeting consumers seeking specialized aesthetic treatments without overlapping service offerings. The company's revenue model relies on direct customer transactions for these branded services, with no mention of additional revenue streams beyond the described service packages. MPM Corporeos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MPM Corporeos stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of MPM Corporeos is 5.61 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of MPM Corporeos changed from 4.27 to 5.61, representing a 31.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) MPM Corporeos since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s MPM Corporeos with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — MPM Corporeos

All Key Metrics — MPM Corporeos